Prokalsitonin, D-dimer, dan Ferritin sebagai Prediktor Perburukan COVID-19
DOI:
https://doi.org/10.55175/cdk.v48i11.149Keywords:
ferritin, prokalsitonin, COVID-19, D-dimerAbstract
Coronavirus disease 2019 (COVID-19) merupakan penyakit sistemik yang klinisnya sangat bervariasi mulai gejala ringan yang memiliki prognosis baik, hingga penyakit berat kritis dengan risiko mortalitas tinggi. Saat ini tidak ada pengobatan spesifik untuk penyakit ini. Adanya penanda yang tepat untuk prediksi tingkat keparahan dan prognosis penting untuk mengurangi mortalitas. Kadar prokalsitonin, D-dimer, dan ferritin serum yang meningkat dapat memprediksi peningkatan risiko perburukan pasien COVID-19.
Coronavirus disease 2019 (COVID-19) is a systemic disease with variable clinical features from mild symptoms with a good prognosis, to critically severe disease with high mortality. Currently, there is no specific treatment for this disease. It is crucial to find appropriate biomarkers to predict severity and prognosis, thus may reduce the mortality rate in COVID-19 patients. Increased procalcitonin, D-dimer, and serum ferritin levels can predict an increased deterioration risk in COVID-19 patients.
Downloads
References
Krause M, Douin DJ, Tran TT, Fernandez-Bustamante A, Aftab M, Bartels K. Association between procalcitonin levels and duration of mechanical ventilation in COVID-19 patients. PLoS ONE 2020;15(9):e0239174.
Vazzana N, Dipaola F, Ognibene S. Procalcitonin and secondary bacterial infections in COVID-19: Association with disease severity and outcomes. Acta Clinica Belgica. 2020;1-5.
Xu JB, Xu C, Zhang RB, Wu M, P CK, Li XJ, et al. Associations of procalcitonin, C‑reaction proteinand neutrophil‑to‑lymphocyte ratio with mortality in hospitalized COVID‑19 patients in China. Scient Rep. 2020;10:15058.
Yu HH, Qin C,Chen M, Wang W, Tian DS. D-dimer level is associated with the severity of COVID-19. Thrombosis Res. 2020;219-25.
Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. J Infection 2020 ;81(4):647-79.
Fauter M, Viel S, Zaepfel S, Pradat P, Fiscus J, Villard M. Low glycosylated ferritin is a sensitive biomarker of severe COVID-19. Cellular Molecular Immunol. 2020;17(11):1183-5.
Liu ZM, Li JP, Wang SP, Chen DY, Zeng W, Chen SC, et al. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19. Internat J Med Sci. 2020;17(16):2468-76.
Liu F, Li L, Xu MD, Wu J, Luo D, Zhu YS, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370.
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clinica Chimica Acta. 2020;505:190–1.
Yan ST, Sun LC, Jia HB, Gao W, Yang JP, Zhang. GQ. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med. 2017;35(4):579-83.
Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Internat J Antimicrob Agents. 2020;56(2):106051.
Berger JS, Kunichoff D, Adhikari S, Ahuja T, Amoroso N, Aphinyaphongs Y, et al. Prevalence and outcomes of D-Dimer elevation in hospitalized patients with COVID-19. Arterioscler Thromb Vasc Biol. 2020;40:00–00.
Sakka M, Connors JM, Hékimian G, Martin-Toutain I, Crichi B, Colmegna I, et al. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and pooled analysis. JMV—Journal de Médecine Vasculaire. 2020;45(5):268–74.
Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, et al. D-Dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. BioMed Res Internat. 2020;2020:6159720.
Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A. D-Dimer concentrations and COVID-19 severity: A systematic review and meta-analysis. Frontiers in Public Health 2020;8:432.
Gómez-Pastora J, Weigand M, Kim J, Wu X, Strayer J, Palmer AF, et al. Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator? Clin Chimica Acta. 2020;509:249–51.
Payán-Pernía S, Pérez LG, Sevilla AFR, Gil JS, Canales SN. Absolute lymphocytes, ferritin, C-reactive protein, and lactate dehydrogenase predict early invasive ventilation in patients with COVID-19. Lab Med. 2021;52(2):141-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
